Intermediate filaments are important for astrocyte response to oxidative stress induced by oxygen-glucose deprivation and reperfusion
In the study by Kim et al., agmatine sulfate (25, 50, and 100 mg/kg) or saline was supplemented in the VPA model via intraperitoneal injection 30 min before each behavior test ( Naringenin Naringenin (5,7-Dihydroxy-2-(4-hydroxy phenyl) chroman-4-one) is a flavanone abundantly found in grapefruit, orange, and tomato peels (74)
In addition, Fusicatenibacter and Sutterella can serve as potential biomarkers for PSO diagnosis, while Lachnospiraceae_GCA-900066575, Escherichia-Shigella, [Eubacterium]_ventriosum_group , and Lachnospiraceae_NK4A136_group have potential value in discriminating PSO disease remission
Humans need a cell compartment called mitochondria which converts the energy from our food to chemical energy which is needed for conducting cellular functions
CrossRef Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis Jung Hoon Cha, Na Ri Park, Sung Woo Cho, Heechul Nam, Hyun Yang, Eun Sun Jung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung, Si Hyun Bae Frontiers in Immunology .2024;[Epub] CrossRef Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response Camilo Julio Llamoza-Torres, Mara Fuentes-Pardo, Bruno Ramos-Molina Metabolism and Target Organ Damage .2024;[Epub] CrossRef Biological and clinical role of TREM2 in liver diseases Ke Ma, Shouliang Guo, Jin Li, Tao Wei, Tingbo Liang Hepatology Communications .2024;[Epub] CrossRef 12,157 View 374 Download 15 Web of Science Crossref Special Review Steatotic liver disease Abstract PDF The existing term non-alcoholic fatty liver disease (NAFLD) has raised substantial concerns due to its inherent disadvantages of using exclusionary diagnostic criteria and the stigmatizing word fatty. Three pan-national liver associations set out to explore a new nomenclature to replace both NAFLD and its suggested alternative, metabolic (dysfunction)-associated fatty liver disease (MAFLD)
